Another Word For It Patrick Durusau on Topic Maps and Semantic Diversity

March 11, 2013

The Annotation-enriched non-redundant patent sequence databases [Curation vs. Search]

Filed under: Bioinformatics,Biomedical,Marketing,Medical Informatics,Patents,Topic Maps — Patrick Durusau @ 2:01 pm

The Annotation-enriched non-redundant patent sequence databases Weizhong Li, Bartosz Kondratowicz, Hamish McWilliam, Stephane Nauche and Rodrigo Lopez.

Not a real promising title is it? 😉 The reason I cite it here is that by curation, the database is “non-redundant.”

Try searching for some of these sequences at the USPTO and compare the results.

The power of curation will be immediately obvious.

Abstract:

The EMBL-European Bioinformatics Institute (EMBL-EBI) offers public access to patent sequence data, providing a valuable service to the intellectual property and scientific communities. The non-redundant (NR) patent sequence databases comprise two-level nucleotide and protein sequence clusters (NRNL1, NRNL2, NRPL1 and NRPL2) based on sequence identity (level-1) and patent family (level-2). Annotation from the source entries in these databases is merged and enhanced with additional information from the patent literature and biological context. Corrections in patent publication numbers, kind-codes and patent equivalents significantly improve the data quality. Data are available through various user interfaces including web browser, downloads via FTP, SRS, Dbfetch and EBI-Search. Sequence similarity/homology searches against the databases are available using BLAST, FASTA and PSI-Search. In this article, we describe the data collection and annotation and also outline major changes and improvements introduced since 2009. Apart from data growth, these changes include additional annotation for singleton clusters, the identifier versioning for tracking entry change and the entry mappings between the two-level databases.

Database URL: http://www.ebi.ac.uk/patentdata/nr/

Topic maps are curated data. Which one do you prefer?

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress